SCHEMBL5899737

SCHEMBL5899737

O=C(CNS(=O)(=O)c1ccc(Br)cc1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 4/20 0.63
MMP2 P08253 4/20 0.63
MMP13 P45452 3/20 0.63
MMP9 P14780 3/20 0.63
MMP3 P08254 2/20 0.63
MMP7 P09237 2/20 0.63
KAT6A Q92794 3/20 0.56
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
MMP12 P39900 2/20 0.54
GAA P10253 2/20 0.54
MEP1B Q16820 3/20 0.54
MMP14 P50281 3/20 0.54
ADAM17 P78536 2/20 0.54
MMP8 P22894 1/20 0.54
ITGA1 P56199 1/20 0.51
BLM P54132 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
ADAMTS4 O75173 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899544 0.89 KAT6A (0.58) MMP1MMP2MMP13MMP9MMP3
SCHEMBL23014361 0.84 KAT6A (0.58) MMP1MMP2MMP13MMP9MMP3
SCHEMBL5320466 0.84 ALDH1A1 (0.60) MMP1KAT6AMEN1KMT2AMMP12
SCHEMBL5899482 0.84 L3MBTL1 (0.60) MMP1MMP2MMP13MMP9MMP3
SCHEMBL5899477 0.83 KAT6A (0.65) MMP1MMP2MMP13MMP9MMP3
SCHEMBL5899447 0.82 MMP2 (0.70) MMP1MMP2MMP13MMP9KAT6A
SCHEMBL5899481 0.81 ALDH1A1 (0.56) MMP1KAT6AMEN1KMT2AMMP12
SCHEMBL5899467 0.79 KAT6A (0.72) MMP1MMP2MMP13MMP9MMP3
SCHEMBL28642342 0.78 MMP1 (0.52) MMP1MMP2MMP13MMP9MMP3
SCHEMBL28642340 0.78 MMP1 (0.52) MMP1MMP2MMP13MMP9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 MMP1 369/4885MMP2 1212/4885MMP13 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.